Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Reserve your place

FREE WEBINAR: Value-based Contracting in Oncology Pharma, are you ready? Friday 3rd February, 2017 : 2pm EST / 11am PST

CMS and private payers have reached a tipping point for uncontrolled inflation in cancer spend. In 2017, more oncologists than ever are saying bye-bye to “buy-and-bill” and hello to “value-based contracting”. In times where pharma’s fate is defined by a series of presidential tweets on drug prices, it is our commitment to value and outcomes that’s at the center of everyone’s attention.

Join three exclusive panelists for an expert roundtable to analyze how the US Oncology market might be upended by what has now become the new normal in single-payer systems in Europe. As we move beyond the process of care, our panelists will discuss oncology metrics pharma can develop in concert with all stakeholders – a discussion you don’t want to miss.

Sign-up for our free webinar to:

  • Navigate the access challenges associated with performance-based contracts so that your therapy sees expanded uptake among all patients who need it
  • Evaluate the future of discounting as a means of cost-reduction and set the strategy for increasing PBM scrutiny
  • Review the alternative payment model spectrum and position your company in a regime measured by performance and outcomes
  • Can’t make the date? All those who register will receive the full webinar recording, so make sure to sign-up anyway.

Join this roundtable with:

Julie Locklear

Julie Locklear

Vice President & Head, Health Economics & Outcomes Research, EMD SERONO

Leora Schiff

Leora Schiff

Principal, Altius Strategy Consulting

Jennifer Hinkel

Jennifer Hinkel

Partner, McGivney Global Advisors